Mohamad Warda

Title: Mohamad Warda: Innovator in Medical Diagnostics

Introduction

Mohamad Warda is a prominent inventor based in Busan, South Korea. He has made significant contributions to the field of medical diagnostics, particularly in the areas of cancer and preeclampsia detection. With a total of 2 patents, his work is paving the way for advancements in healthcare.

Latest Patents

Warda's latest patents include a groundbreaking invention titled "Mitochondrial enoyl coenzyme A hydratase 1 as marker for diagnosing stomach cancer." This invention relates to a mitochondrial protein that serves as a marker for diagnosing stomach cancer. The marker comprises mitochondrial enoyl coenzyme A hydratase 1, which has the potential to improve early detection of this disease. Another significant patent is "Method for the diagnosis of preeclampsia," which introduces a biomarker and composition for diagnosing preeclampsia. This invention utilizes enzymes such as placental chondroitin 4-O-sulfotransferase 1, chondroitin 6-sulfotransferase, heparan sulfate 6-O-sulfotransferase 1, and dermatan/chondroitin sulfate 2-sulfotransferase, or uronic acid-2-sulfate.

Career Highlights

Warda is affiliated with the Inje University Industry-Academic Cooperation Foundation, where he continues to engage in innovative research and development. His work is characterized by a commitment to enhancing diagnostic methods that can lead to better patient outcomes.

Collaborations

Warda collaborates with notable colleagues, including Won Sun Park and Na Ri Kim. Their combined expertise contributes to the advancement of medical technologies and innovations.

Conclusion

Mohamad Warda's contributions to medical diagnostics through his patents are significant. His work not only showcases his innovative spirit but also highlights the importance of research in improving healthcare solutions.